Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.300 Biomarker disease CTD_human Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. 20208537 2010
Entrez Id: 55129
Gene Symbol: ANO10
ANO10
0.300 Biomarker disease CTD_human
Entrez Id: 334
Gene Symbol: APLP2
APLP2
0.010 Biomarker disease BEFREE Our data suggest that the interaction between APLP2 and ataxin-7 and proteolytic processing of APLP2 may contribute to the pathogenesis of SCA7. 20732423 2011
Entrez Id: 9140
Gene Symbol: ATG12
ATG12
0.010 Biomarker disease BEFREE Interestingly, the expression of the early autophagy-associated gene ATG12 was increased in PBMC from SCA7 patients in correlation with disease severity. 24859968 2014
Entrez Id: 1822
Gene Symbol: ATN1
ATN1
0.010 Biomarker disease BEFREE Except for individuals with spinocerebellar ataxia type 1, age at onset was also influenced by other (CAG)n-containing genes: ATXN7 in spinocerebellar ataxia type 2; ATXN2, ATN1 and HTT in spinocerebellar ataxia type 3; ATXN1 and ATXN3 in spinocerebellar ataxia type 6; and ATXN3 and TBP in spinocerebellar ataxia type 7. 24972706 2014
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 Biomarker disease CTD_human Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. 18337722 2008
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 GeneticVariation disease BEFREE Thirty-five patients belonged to the ADCA type I group (SCA1, 12; SCA2, 10; SCA3, 13) and five to the ADCA type II group. 10366224 1999
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 Biomarker disease BEFREE SCA1 and SCA7 patients had African ancestry. 19659750 2010
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 AlteredExpression disease BEFREE Except for individuals with spinocerebellar ataxia type 1, age at onset was also influenced by other (CAG)n-containing genes: ATXN7 in spinocerebellar ataxia type 2; ATXN2, ATN1 and HTT in spinocerebellar ataxia type 3; ATXN1 and ATXN3 in spinocerebellar ataxia type 6; and ATXN3 and TBP in spinocerebellar ataxia type 7. 24972706 2014
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 Biomarker disease CTD_human Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. 17322884 2007
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 Biomarker disease CTD_human The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. 16122429 2005
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.330 Biomarker disease CTD_human Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro. 11719269 2002
Entrez Id: 342371
Gene Symbol: ATXN1L
ATXN1L
0.300 Therapeutic disease CTD_human Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. 17322884 2007
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.320 Biomarker disease BEFREE Using the 1C2 antibody which specifically recognizes large polyglutamine tracts, particularly those that are expanded, we recently reported the detection of proteins with pathological glutamine expansions in lymphoblasts from another form of ADCA type I, SCA2, as well as from patients presenting with the distinct phenotype of ADCA type II. 8968739 1996
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.320 Biomarker disease CTD_human Phenotype variability in spinocerebellar ataxia type 2: a longitudinal family survey and a case featuring an unusual benign course of disease. 19224595 2009
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.320 Biomarker disease CTD_human Levodopa-induced dyskinesias in spinocerebellar ataxia type 2. 20065139 2010
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.320 GeneticVariation disease BEFREE Thirty-five patients belonged to the ADCA type I group (SCA1, 12; SCA2, 10; SCA3, 13) and five to the ADCA type II group. 10366224 1999
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.030 Biomarker disease BEFREE These data confirm that the presence of intranuclear inclusions in neurons is a common characteristic of disorders caused by CAG/polyglutamine expansions, but unlike what has been reported for Huntington's disease, SCA1 and SCA3/MJD, in SCA7 the inclusions were not restricted to the sites of severe neuronal loss. 9536097 1998
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.030 Biomarker disease BEFREE Except for individuals with spinocerebellar ataxia type 1, age at onset was also influenced by other (CAG)n-containing genes: ATXN7 in spinocerebellar ataxia type 2; ATXN2, ATN1 and HTT in spinocerebellar ataxia type 3; ATXN1 and ATXN3 in spinocerebellar ataxia type 6; and ATXN3 and TBP in spinocerebellar ataxia type 7. 24972706 2014
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.030 GeneticVariation disease BEFREE Thirty-five patients belonged to the ADCA type I group (SCA1, 12; SCA2, 10; SCA3, 13) and five to the ADCA type II group. 10366224 1999
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.800 Biomarker disease BEFREE The location of the putative SCA7 nuclear localization sequence (NLS) was confirmed by fusing an ataxin-7 fragment with the normally cytoplasmic protein chicken muscle pyruvate kinase. 10441328 1999
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.800 GeneticVariation disease BEFREE Spinocerebellar ataxia type 7 (SCA7) is a retinal-cerebellar degenerative disorder caused by CAG-polyglutamine (polyQ) repeat expansions in the ataxin-7 gene. 30699348 2019
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.800 Biomarker disease BEFREE Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7). 19172503 2009
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.800 Biomarker disease BEFREE Furthermore, SUMO1 and SUMO2 colocalized with ATXN7 in a subset of neuronal intranuclear inclusions in the brain of SCA7 patients and SCA7 knock-in mice. 19843541 2010
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.800 Biomarker disease MGD SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. 12575948 2003